Compile Data Set for Download or QSAR

Found 22 hits Enz. Inhib. hit(s) with all data for entry = 6906   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Adenosine receptor A2a (Homo sapiens (Human))	BDBM158419 (US9029393, 97) Show SMILES Cn1nc(-c2cnc3ccc(F)cn23)c2ccc(cc12)C(=O)N1CCCCCCC1 Show InChI InChI=1S/C23H24FN5O/c1-27-19-13-16(23(30)28-11-5-3-2-4-6-12-28)7-9-18(19)22(26-27)20-14-25-21-10-8-17(24)15-29(20)21/h7-10,13-15H,2-6,11-12H2,1H3	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Kaldi Pharma, SAS US Patent					Assay Description Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...				US Patent US9029393 (2015) BindingDB Entry DOI: 10.7270/Q2D50KQH
					More data for this Ligand-Target Pair
Adenosine receptor A2a (Homo sapiens (Human))	BDBM50011298 (CHEMBL3260730 | US9029393, 101) Show SMILES COC[C@H]1CCCN1C(=O)c1ccc2c(nn(C)c2c1)-c1cnc2ccc(cn12)C#N |r| Show InChI InChI=1S/C23H22N6O2/c1-27-19-10-16(23(30)28-9-3-4-17(28)14-31-2)6-7-18(19)22(26-27)20-12-25-21-8-5-15(11-24)13-29(20)21/h5-8,10,12-13,17H,3-4,9,14H2,1-2H3/t17-/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	US Patent	3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Kaldi Pharma, SAS US Patent					Assay Description Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...				US Patent US9029393 (2015) BindingDB Entry DOI: 10.7270/Q2D50KQH
					More data for this Ligand-Target Pair
Adenosine receptor A2a (Homo sapiens (Human))	BDBM50011299 (CHEMBL3260731 | US9029393, 113) Show SMILES Fc1ccc2ncc(-c3noc4cc(ccc34)C(=O)N3CCCCCC3)n2c1 Show InChI InChI=1S/C21H19FN4O2/c22-15-6-8-19-23-12-17(26(19)13-15)20-16-7-5-14(11-18(16)28-24-20)21(27)25-9-3-1-2-4-10-25/h5-8,11-13H,1-4,9-10H2	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem	US Patent	4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Kaldi Pharma, SAS US Patent					Assay Description Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...				US Patent US9029393 (2015) BindingDB Entry DOI: 10.7270/Q2D50KQH
					More data for this Ligand-Target Pair
Adenosine receptor A2a (Homo sapiens (Human))	BDBM158417 (US9029393, 79) Show SMILES Cn1nc(-c2cnc3ccc(F)cn23)c2ccc(cc12)C(=O)N1CCCCCC1 Show InChI InChI=1S/C22H22FN5O/c1-26-18-12-15(22(29)27-10-4-2-3-5-11-27)6-8-17(18)21(25-26)19-13-24-20-9-7-16(23)14-28(19)20/h6-9,12-14H,2-5,10-11H2,1H3	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Kaldi Pharma, SAS US Patent					Assay Description Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...				US Patent US9029393 (2015) BindingDB Entry DOI: 10.7270/Q2D50KQH
					More data for this Ligand-Target Pair
Adenosine receptor A2a (Homo sapiens (Human))	BDBM50011297 (CHEMBL3260729 | US9029393, 14) Show SMILES Fc1ccc2ncc(C(=O)c3ccc(cc3)C(=O)N3CCCCCC3)n2c1 Show InChI InChI=1S/C21H20FN3O2/c22-17-9-10-19-23-13-18(25(19)14-17)20(26)15-5-7-16(8-6-15)21(27)24-11-3-1-2-4-12-24/h5-10,13-14H,1-4,11-12H2	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	US Patent	12	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Kaldi Pharma, SAS US Patent					Assay Description Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...				US Patent US9029393 (2015) BindingDB Entry DOI: 10.7270/Q2D50KQH
					More data for this Ligand-Target Pair
Adenosine receptor A2a (Homo sapiens (Human))	BDBM158412 (US9029393, 24) Show SMILES CCN(C1CCCCC1)C(=O)c1ccc(cc1Cl)C(=O)c1cnc2ccc(F)cn12 Show InChI InChI=1S/C23H23ClFN3O2/c1-2-27(17-6-4-3-5-7-17)23(30)18-10-8-15(12-19(18)24)22(29)20-13-26-21-11-9-16(25)14-28(20)21/h8-14,17H,2-7H2,1H3	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	34	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Kaldi Pharma, SAS US Patent					Assay Description Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...				US Patent US9029393 (2015) BindingDB Entry DOI: 10.7270/Q2D50KQH
					More data for this Ligand-Target Pair
Adenosine receptor A2a (Homo sapiens (Human))	BDBM158420 (US9029393, 107) Show SMILES Fc1ccc2ncc(-c3nn(Cc4ccccc4)c4cc(ccc34)C(=O)N3CCCCCC3)n2c1 Show InChI InChI=1S/C28H26FN5O/c29-22-11-13-26-30-17-25(33(26)19-22)27-23-12-10-21(28(35)32-14-6-1-2-7-15-32)16-24(23)34(31-27)18-20-8-4-3-5-9-20/h3-5,8-13,16-17,19H,1-2,6-7,14-15,18H2	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	34	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Kaldi Pharma, SAS US Patent					Assay Description Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...				US Patent US9029393 (2015) BindingDB Entry DOI: 10.7270/Q2D50KQH
					More data for this Ligand-Target Pair
Adenosine receptor A2a (Homo sapiens (Human))	BDBM158424 (US9029393, 132) Show SMILES Fc1ccc2ncc(-n3nnc4cc(ccc34)C(=O)N3CCCCCC3)n2c1 Show InChI InChI=1S/C20H19FN6O/c21-15-6-8-18-22-12-19(26(18)13-15)27-17-7-5-14(11-16(17)23-24-27)20(28)25-9-3-1-2-4-10-25/h5-8,11-13H,1-4,9-10H2	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	72	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Kaldi Pharma, SAS US Patent					Assay Description Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...				US Patent US9029393 (2015) BindingDB Entry DOI: 10.7270/Q2D50KQH
					More data for this Ligand-Target Pair
Adenosine receptor A2a (Homo sapiens (Human))	BDBM158426 (US9029393, 136) Show SMILES Nc1nc(-c2cnc3ccc(F)cn23)c2ccc(cc2n1)C(=O)N1CCCCCC1 Show InChI InChI=1S/C22H21FN6O/c23-15-6-8-19-25-12-18(29(19)13-15)20-16-7-5-14(11-17(16)26-22(24)27-20)21(30)28-9-3-1-2-4-10-28/h5-8,11-13H,1-4,9-10H2,(H2,24,26,27)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	84	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Kaldi Pharma, SAS US Patent					Assay Description Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...				US Patent US9029393 (2015) BindingDB Entry DOI: 10.7270/Q2D50KQH
					More data for this Ligand-Target Pair
Adenosine receptor A2a (Homo sapiens (Human))	BDBM158413 (US9029393, 30) Show SMILES Nc1cc(ccc1C(=O)c1cnc2ccc(F)cn12)C(=O)N1CCCCCC1 Show InChI InChI=1S/C21H21FN4O2/c22-15-6-8-19-24-12-18(26(19)13-15)20(27)16-7-5-14(11-17(16)23)21(28)25-9-3-1-2-4-10-25/h5-8,11-13H,1-4,9-10,23H2	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	103	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Kaldi Pharma, SAS US Patent					Assay Description Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...				US Patent US9029393 (2015) BindingDB Entry DOI: 10.7270/Q2D50KQH
					More data for this Ligand-Target Pair
Adenosine receptor A2a (Homo sapiens (Human))	BDBM158410 (US9029393, 10) Show SMILES CCN(C1CCCCC1)C(=O)c1ccc(cc1)C(=O)c1cnc2ccc(Br)cn12 Show InChI InChI=1S/C23H24BrN3O2/c1-2-26(19-6-4-3-5-7-19)23(29)17-10-8-16(9-11-17)22(28)20-14-25-21-13-12-18(24)15-27(20)21/h8-15,19H,2-7H2,1H3	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	108	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Kaldi Pharma, SAS US Patent					Assay Description Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...				US Patent US9029393 (2015) BindingDB Entry DOI: 10.7270/Q2D50KQH
					More data for this Ligand-Target Pair
Adenosine receptor A2a (Homo sapiens (Human))	BDBM158414 (US9029393, 48) Show SMILES O=C(N(C1CCCCC1)C1CCCCC1)c1ccc(cc1)C(=O)c1cnc2ccccn12 Show InChI InChI=1S/C27H31N3O2/c31-26(24-19-28-25-13-7-8-18-29(24)25)20-14-16-21(17-15-20)27(32)30(22-9-3-1-4-10-22)23-11-5-2-6-12-23/h7-8,13-19,22-23H,1-6,9-12H2	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	138	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Kaldi Pharma, SAS US Patent					Assay Description Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...				US Patent US9029393 (2015) BindingDB Entry DOI: 10.7270/Q2D50KQH
					More data for this Ligand-Target Pair
Adenosine receptor A2a (Homo sapiens (Human))	BDBM158422 (US9029393, 125) Show SMILES O=C(N1CCOCC1)c1ccc2c(noc2c1)-c1cnc2ccc(cn12)[N+]#[C-] Show InChI InChI=1S/C20H15N5O3/c1-21-14-3-5-18-22-11-16(25(18)12-14)19-15-4-2-13(10-17(15)28-23-19)20(26)24-6-8-27-9-7-24/h2-5,10-12H,6-9H2	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	147	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Kaldi Pharma, SAS US Patent					Assay Description Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...				US Patent US9029393 (2015) BindingDB Entry DOI: 10.7270/Q2D50KQH
					More data for this Ligand-Target Pair
Adenosine receptor A2a (Homo sapiens (Human))	BDBM158416 (US9029393, 71) Show SMILES O=C(N1CCCc2ccccc12)c1ccc(cc1)C(=O)c1cnc2ccccn12 Show InChI InChI=1S/C24H19N3O2/c28-23(21-16-25-22-9-3-4-14-26(21)22)18-10-12-19(13-11-18)24(29)27-15-5-7-17-6-1-2-8-20(17)27/h1-4,6,8-14,16H,5,7,15H2	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	171	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Kaldi Pharma, SAS US Patent					Assay Description Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...				US Patent US9029393 (2015) BindingDB Entry DOI: 10.7270/Q2D50KQH
					More data for this Ligand-Target Pair
Adenosine receptor A2a (Homo sapiens (Human))	BDBM158409 (US9029393, 7) Show SMILES CCN(C1CCCCC1)C(=O)c1ccc(cc1)C(=O)c1cnc2ccc(cn12)[N+]#[C-] Show InChI InChI=1S/C24H24N4O2/c1-3-27(20-7-5-4-6-8-20)24(30)18-11-9-17(10-12-18)23(29)21-15-26-22-14-13-19(25-2)16-28(21)22/h9-16,20H,3-8H2,1H3	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	171	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Kaldi Pharma, SAS US Patent					Assay Description Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...				US Patent US9029393 (2015) BindingDB Entry DOI: 10.7270/Q2D50KQH
					More data for this Ligand-Target Pair
Adenosine receptor A2a (Homo sapiens (Human))	BDBM158418 (US9029393, 85) Show SMILES Cn1nc(-c2cnc3ccc(cn23)C(F)(F)F)c2ccc(cc12)C(=O)N1CCCCCC1 Show InChI InChI=1S/C23H22F3N5O/c1-29-18-12-15(22(32)30-10-4-2-3-5-11-30)6-8-17(18)21(28-29)19-13-27-20-9-7-16(14-31(19)20)23(24,25)26/h6-9,12-14H,2-5,10-11H2,1H3	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	177	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Kaldi Pharma, SAS US Patent					Assay Description Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...				US Patent US9029393 (2015) BindingDB Entry DOI: 10.7270/Q2D50KQH
					More data for this Ligand-Target Pair
Adenosine receptor A2a (Homo sapiens (Human))	BDBM158415 (US9029393, 56) Show SMILES CCN(C(=O)c1ccc(cc1)C(=O)c1cnc2ccccn12)c1ccccc1 Show InChI InChI=1S/C23H19N3O2/c1-2-25(19-8-4-3-5-9-19)23(28)18-13-11-17(12-14-18)22(27)20-16-24-21-10-6-7-15-26(20)21/h3-16H,2H2,1H3	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	188	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Kaldi Pharma, SAS US Patent					Assay Description Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...				US Patent US9029393 (2015) BindingDB Entry DOI: 10.7270/Q2D50KQH
					More data for this Ligand-Target Pair
Adenosine receptor A2a (Homo sapiens (Human))	BDBM158423 (US9029393, 129) Show SMILES CCN(C1CCCCC1)C(=O)c1ccc2nc(oc2c1)-c1cnc2ccccn12 Show InChI InChI=1S/C23H24N4O2/c1-2-26(17-8-4-3-5-9-17)23(28)16-11-12-18-20(14-16)29-22(25-18)19-15-24-21-10-6-7-13-27(19)21/h6-7,10-15,17H,2-5,8-9H2,1H3	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	256	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Kaldi Pharma, SAS US Patent					Assay Description Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...				US Patent US9029393 (2015) BindingDB Entry DOI: 10.7270/Q2D50KQH
					More data for this Ligand-Target Pair
Adenosine receptor A2a (Homo sapiens (Human))	BDBM158411 (US9029393, 23) Show SMILES CCN(C1CCCCC1)C(=O)c1ccc(nc1)C(=O)c1cnc2ccccn12 Show InChI InChI=1S/C22H24N4O2/c1-2-25(17-8-4-3-5-9-17)22(28)16-11-12-18(23-14-16)21(27)19-15-24-20-10-6-7-13-26(19)20/h6-7,10-15,17H,2-5,8-9H2,1H3	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	264	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Kaldi Pharma, SAS US Patent					Assay Description Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...				US Patent US9029393 (2015) BindingDB Entry DOI: 10.7270/Q2D50KQH
					More data for this Ligand-Target Pair
Adenosine receptor A2a (Homo sapiens (Human))	BDBM158421 (US9029393, 111) Show SMILES CN1CCN(CC1)C(=O)n1nc(-c2cnc3ccc(F)cn23)c2ccc(cc12)C(=O)N1CCCCCC1 Show InChI InChI=1S/C27H30FN7O2/c1-31-12-14-33(15-13-31)27(37)35-22-16-19(26(36)32-10-4-2-3-5-11-32)6-8-21(22)25(30-35)23-17-29-24-9-7-20(28)18-34(23)24/h6-9,16-18H,2-5,10-15H2,1H3	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	291	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Kaldi Pharma, SAS US Patent					Assay Description Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...				US Patent US9029393 (2015) BindingDB Entry DOI: 10.7270/Q2D50KQH
					More data for this Ligand-Target Pair
Adenosine receptor A2a (Homo sapiens (Human))	BDBM158425 (US9029393, 134) Show SMILES Fc1ccc2ncc(-c3c[nH]c4cc(ccc34)C(=O)N3CCCCCC3)n2c1 Show InChI InChI=1S/C22H21FN4O/c23-16-6-8-21-25-13-20(27(21)14-16)18-12-24-19-11-15(5-7-17(18)19)22(28)26-9-3-1-2-4-10-26/h5-8,11-14,24H,1-4,9-10H2	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	348	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Kaldi Pharma, SAS US Patent					Assay Description Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...				US Patent US9029393 (2015) BindingDB Entry DOI: 10.7270/Q2D50KQH
					More data for this Ligand-Target Pair
Adenosine receptor A2a (Homo sapiens (Human))	BDBM158427 (US9029393, 139) Show SMILES CCN(C1CCCCC1)C(=O)c1ccc(cc1)C(=O)c1cnc2ccc(Cl)nn12 Show InChI InChI=1S/C22H23ClN4O2/c1-2-26(17-6-4-3-5-7-17)22(29)16-10-8-15(9-11-16)21(28)18-14-24-20-13-12-19(23)25-27(18)20/h8-14,17H,2-7H2,1H3	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	459	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Kaldi Pharma, SAS US Patent					Assay Description Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...				US Patent US9029393 (2015) BindingDB Entry DOI: 10.7270/Q2D50KQH
					More data for this Ligand-Target Pair